ERNA Ernexa Therapeutics Inc. - Common Stock
$11.29
Price · May 20, 2026
Fundamentals as of May 11, 2026
52W Range
$0–$16
71% of range
Analyst Rating
HOLD
6 analysts
Price Target
$30
+166% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
ERNA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$11.29
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$0 – $16
ERNA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
ERNA
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
ERNA
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
ERNA
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
ERNA
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
ERNA
Peer Median
ERNA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
SELL
6 analysts
- Strong Buy 0 0.0%
- Buy 0 0.0%
- Hold 3 50.0%
- Sell 1 16.7%
- Strong Sell 2 33.3%
12-Month Price Target
1 analysts · 2026-05-16
Low
$30.00
High
$30.00
Median target
$30.00
+165.7%
Mean target
$30.00
+165.7%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
82.8%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| Sept. 30, 2023 | $-1.03 | — | — |
| Sept. 30, 2022 | $-933.75 | $-841.50 | -92.2% |
| June 30, 2022 | $-450.00 | $-994.50 | 544.5% |
| March 31, 2022 | $-1275.00 | $-1071.00 | -204.0% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ERNA | — | — | — | — | — | — |
| CYCN | — | -1.1 | 3.7% | — | — | — |
| MBRX | — | — | — | — | — | — |
| PHIO | $12M | -0.2 | — | — | -57.5% | — |
| INTS | $1M | -0.0 | — | — | -165.1% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 11
| Metric | Trend | Q1 2026 |
|---|---|---|
| SG&A Expense | $2M | |
| Operating Expenses | $6M | |
| Operating Income | $-6M | |
| Pretax Income | $-6M | |
| Income Tax | $-40.0K | |
| Net Income | $-6M | |
| EPS (Basic) | $-6.95 | |
| EPS (Diluted) | $-6.95 | |
| Shares (Basic) | 792,000 | |
| Shares (Diluted) | 792,000 | |
| EBITDA | $-6M |
Balance Sheet 18
| Metric | Trend | Q1 2026 |
|---|---|---|
| Cash & Equivalents | $9M | |
| Prepaid Expense | $724.0K | |
| Current Assets | $10M | |
| PP&E (Net) | $88.0K | |
| Other Non-current Assets | $110.0K | |
| Total Assets | $11M | |
| Accounts Payable | $1M | |
| Accrued Liabilities | $1M | |
| Current Liabilities | $3M | |
| Capital Leases | $226.0K | |
| Other Non-current Liabilities | $1.0K | |
| Total Liabilities | $4M | |
| Common Stock | $6.0K | |
| Paid-in Capital | $258M | |
| Retained Earnings | $-251M | |
| Stockholders' Equity | $7M | |
| Liabilities + Equity | $11M | |
| Shares Outstanding | 1,166,000 |
Cash Flow 10
| Metric | Trend | Q1 2026 |
|---|---|---|
| D&A | $8.0K | |
| Stock-based Comp | $309.0K | |
| Other Non-cash | $3M | |
| Operating Cash Flow | $-2M | |
| CapEx | $2.0K | |
| Investing Cash Flow | $-2.0K | |
| Stock Issued | $10M | |
| Net Stock Activity | $10M | |
| Financing Cash Flow | $10M | |
| Free Cash Flow | $-2M |
Profitability 3
| Metric | Trend | Q1 2026 |
|---|---|---|
| ROA | -70.6% | |
| ROE | -1211.4% | |
| ROIC | -80.9% |
Liquidity & Solvency 2
| Metric | Trend | Q1 2026 |
|---|---|---|
| Current Ratio | 2.9 | |
| Quick Ratio | 2.7 |
Valuation (TTM) 10
| Metric | Trend | Q1 2026 |
|---|---|---|
| Revenue TTM | $632.0K | |
| Net Income TTM | $-18M | |
| Market Cap | $233.2K | |
| P/E | -0.0 | |
| P/S | 0.4 | |
| P/B | 0.0 | |
| P / Tangible Book | 0.0 | |
| P / Cash Flow | -0.1 | |
| P / FCF | -0.1 | |
| Earnings Yield | -32735.0% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.